Outlook Therapeutics (OTLK) Tax Provisions: 2015-2020
Historic Tax Provisions for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2020 value amounting to -$805.
- Outlook Therapeutics' Tax Provisions rose 99.97% to -$805 in Q3 2020 from the same period last year, while for Sep 2020 it was -$6.7 million, marking a year-over-year increase of 5.33%. This contributed to the annual value of $2,800 for FY2024, which is negligibly% changed negligibly from last year.
- As of Q3 2020, Outlook Therapeutics' Tax Provisions stood at -$805, which was up 99.98% from -$3.3 million recorded in Q2 2020.
- Over the past 5 years, Outlook Therapeutics' Tax Provisions peaked at $497,500 during Q3 2017, and registered a low of -$3.3 million during Q2 2020.
- For the 3-year period, Outlook Therapeutics' Tax Provisions averaged around -$1.4 million, with its median value being -$777,500 (2019).
- As far as peak fluctuations go, Outlook Therapeutics' Tax Provisions tumbled by 78,867.90% in 2017, and later spiked by 99.97% in 2020.
- Outlook Therapeutics' Tax Provisions (Quarterly) stood at $4,000 in 2016, then plummeted by 78,867.90% to -$3.2 million in 2017, then crashed by 200.00% to -$497,500 in 2018, then slumped by 429.35% to -$2.6 million in 2019, then surged by 99.97% to -$805 in 2020.
- Its Tax Provisions was -$805 in Q3 2020, compared to -$3.3 million in Q2 2020 and -$2.6 million in Q3 2019.